Segment Information (Tables)

6 Months Ended

Dec. 31, 2023

Segment Reporting [Abstract]

Disaggregation of Revenue [Table Text Block]

	Three Months Ended December 31,
(in millions)	2023		2022
Pharmaceutical and Specialty Pharmaceutical Distribution and Services (1)	$	53,190	$	47,391
Nuclear and Precision Health Solutions	330		282
Pharmaceutical segment revenue	53,520		47,673
Medical Products and Distribution (2)	3,167		3,099
Cardinal Health at-Home Solutions	761		698
Medical segment revenue	3,928		3,797
Total segment revenue	57,448		51,470
Corporate (3)	(3)		(1)
Total revenue	$	57,445	$	51,469

	Six Months Ended December 31,
(in millions)	2023		2022
Pharmaceutical and Specialty Pharmaceutical Distribution and Services (1)	$	103,872	$	92,938
Nuclear and Precision Health Solutions	654		563
Pharmaceutical segment revenue	104,526		93,501
Medical Products and Distribution (2)	6,243		6,239
Cardinal Health at-Home Solutions	1,445		1,336
Medical segment revenue	7,688		7,575
Total segment revenue	112,214		101,076
Corporate (3)	(6)		(4)
Total revenue	$	112,208	$	101,072

(1)Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.

(2)Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division.

(3)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.

Revenue from External Customers by Geographic Areas [Table Text Block]

The following tables present revenue by geographic area:

	Three Months Ended December 31,
(in millions)	2023		2022
United States	$	56,241	$	50,333
International	1,207		1,137
Total segment revenue	57,448		51,470
Corporate (1)	(3)		(1)
Total revenue	$	57,445	$	51,469

	Six Months Ended December 31,
(in millions)	2023		2022
United States	$	109,798	$	98,810
International	2,416		2,266
Total segment revenue	112,214		101,076
Corporate (1)	(6)		(4)
Total revenue	$	112,208	$	101,072

(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.

Segment Profit by Reportable Segment

The following tables present segment profit by reportable segment and Corporate:

	Three Months Ended December 31,
(in millions)	2023		2022
Pharmaceutical	$	518	$	464
Medical	71		17
Total segment profit	589		481
Corporate	(107)		(600)
Total operating earnings/(loss)	$	482	$	(119)

	Six Months Ended December 31,
(in millions)	2023		2022
Pharmaceutical	$	1,025	$	895
Medical	142		9
Total segment profit	1,167		904
Corporate	(699)		(886)
Total operating earnings/(loss)	$	468	$	18

Assets by Reportable Segment

The following table presents total assets for each reportable segment and Corporate at:

(in millions)	December 31, 2023		June 30, 2023
Pharmaceutical	$	31,018	$	28,077
Medical	9,817		10,130
Corporate	5,738		5,210
Total assets	$	46,573	$	43,417